GOVXGeoVax Labs, Inc.

Nasdaq geovax.com


$ 2.05 $ -0.08 (-3.76 %)    

Wednesday, 26-Jun-2024 09:43:31 EDT
QQQ $ 479.83 $ 0.23 (0.05 %)
DIA $ 389.47 $ -1.55 (-0.4 %)
SPY $ 544.15 $ 0.55 (0.1 %)
TLT $ 93.36 $ -0.19 (-0.21 %)
GLD $ 212.50 $ -1.69 (-0.79 %)
$ 2.2
$ 2.13
$ 0.00 x 0
$ 2.07 x 200
$ 1.96 - $ 2.13
$ 1.09 - $ 10.24
1,456,260
na
5.08M
$ -15.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 03-09-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-24-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-26-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 03-23-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-24-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 03-16-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-20-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Bloomberg

 geovax-labs-shares-resume-trade
GeoVax Labs Shares Resume Trade
06/18/2024 17:27:45

 hc-wainwright--co-maintains-buy-on-geovax-labs-adjusts-price-target-to-120-1-15-reverse-stock-split

HC Wainwright & Co. analyst Vernon Bernardino maintains Geovax Labs (NASDAQ:GOVX) with a Buy, adjusts target to $120 from $...

 geovax-labs-gets-barda-project-nextgen-award-to-conduct-phase-2b-clinical-study-evaluating-next-generation-covid-19-vaccine-candidate-geo-cm04s1-direct-award-to-geovax-of-243m-which-may-increase-to-as-much-as-45m

- Reuters

 elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

Core News & Articles

https://twitter.com/DrTedros/status/1778423967105139108  

 geovax-to-present-data-on-geo-cm04s1-a-next-generation-covid-19-vaccine-at-the-world-vaccine-congress

GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...

 geovax-labs-inc-files-for-mixed-shelf-of-up-to-100m

– SEC Filing

 geovax-labs-q4-earnings-insights
Geovax Labs: Q4 Earnings Insights
02/29/2024 21:10:39

 geovax-labs-q4-2023-gaap-eps-3940-misses-2780-estimate

Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(3.940) per share which missed the analyst consensus estimate of $(2.78...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION